Stockscreener 앱 받기
5.14
3.75%
-0.20
시간 외 거래:
5.18
0.04
+0.78%
전일 마감가:
$5.34
열려 있는:
$5.43
하루 거래량:
12,331
Relative Volume:
0.19
시가총액:
$133.71M
수익:
$40,000
순이익/손실:
$-67.82M
주가수익비율:
-1.4445
EPS:
-3.5583
순현금흐름:
$-20.86M
1주 성능:
-6.20%
1개월 성능:
+7.53%
6개월 성능:
-40.06%
1년 성능:
-28.81%
1일 변동 폭
$5.09
$5.43
1주일 범위
$5.09
$5.66
52주 변동 폭
$3.20
$12.99
Neonc Technologies Holdings Inc Stock (NTHI) Company Profile
명칭
Neonc Technologies Holdings Inc
전화
310 663 7831
주소
23975 PARK SORRENTO, CALABASAS
Compare NTHI vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NTHI
Neonc Technologies Holdings Inc
|
5.14 | 138.91M | 40,000 | -67.82M | -20.86M | -3.5583 |
VRTX
Vertex Pharmaceuticals Inc
|
435.93 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.62 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.43 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Neonc Technologies Holdings Inc 주식(NTHI)의 최신 뉴스
NeOnc Technologies Holdings (NTHI) Holds Near Support as Modest Decline Tests Key LevelFactor Valuation - Newser
NTHI Initiated Coverage by Alliance Global Partners -- Rating Se - GuruFocus
NeOnc Technologies Gains Growing Institutional Support Ahead of Key Brain Cancer Clinical Milestones - The Manila Times
NeOnc Technologies Gains Analyst Favor with Growing Insider and Institutional Interest in CNS Cancer Therapies - Quiver Quantitative
Wall Street firms back brain-cancer biotech as trial data nears - Stock Titan
A. G. P. Initiates NeOnc Technologies(NTHI.US) With Buy Rating, Announces Target Price $13 - Moomoo
NeOnc Technologies Reports Q1 2026 Results: Advancing Phase 2 CNS Cancer Trials and Strengthening Financial Position 1 2 3 - Minichart
NeOnc Provides Business Update and Reports Q1 2026 Financial Results - Sahm
NeOnc Advances Glioma Programs and Strengthens Financial Position - TipRanks
NeOnc Technologies Price Target Announced at $20.00/Share by Maxim Group - Moomoo
NeOnc Technologies (Nasdaq: NTHI) posts Q1 loss, advances NEO212 and NEO100 - Stock Titan
NeOnc Technologies Holdings, Inc. Reports Q1 2026 Financial Results and Advances Key CNS Cancer Clinical Programs - Quiver Quantitative
Brain cancer drug developer NeOnc eyes FDA talks after $10M investment - Stock Titan
Maxim Group initiates coverage of Neonc Technologies Holdings (NTHI) with buy recommendation - MSN
Cinctive Capital (NTHI) reports 2.48M shares, including 1.06M warrants - Stock Titan
NEONC TECHNOLOGIES HOLDINGS, INC. 1Q 2026: Revenue $0 EPS $(0.38) — 10-Q Summary - TradingView
NeOnc Technologies (NASDAQ: NTHI) burns cash, flags going-concern risk despite $13.1M PIPE - Stock Titan
NeOnc Technologies Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
NeOnc Technologies Holdings, Inc.Common Stock (NQ: NTHI - The Chronicle-Journal
Number of shareholders of NeOnc Technologies Holdings, Inc. – NASDAQ:NTHI - TradingView
Neonc Technologies : NTHI - 24/7 Wall St.
Forget the 242% Biotech Meme. This Brain Cancer Stock Has a $38 Analyst Target and Trades at $6 - Yahoo Finance
NeOnc Technologies Holdings, Inc. (NTHI) Stock Price, News, Quote & History - Yahoo! Finance Canada
NeOnc Technologies (NASDAQ:NTHI) Positioned for Potential Breakthrough in Brain Cancer Treatment Amidst Biotech Market Shift - Quiver Quantitative
A biotech CEO spent $500K+ as a brain cancer trial nears data - Stock Titan
Biotech’s Next Wave May Already be in Motion - marketscreener.com
The quiet strength in NeOnc (NTHI) business model (Surges Ahead) 2026-05-06Day Trade - newser.com
CEO buys $500K+ in brain-cancer biotech with trial data expected - Stock Titan
Where Executives Are Doubling Down on Their Companies’ Fortunes - marketscreener.com
NeOnc Technologies Holdings, Inc. 2025 10-K/A: Executive Compensation, Beneficial Ownership, and Key Agreements Overview - Minichart
NeOnc CEO purchases over $500,000 in company shares By Investing.com - Investing.com South Africa
NeOnc CEO purchases over $500,000 in company shares - Investing.com
NeOnc CEO Accelerates Insider Buying with $500K+ Investment Ahead of Imminent NEO100 Phase 2a Data Catalysts - The Manila Times
$500K more from NeOnc's CEO ahead of brain cancer drug data - Stock Titan
NeOnc Technologies Holdings Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView
Executive pay, ownership and governance at NeOnc Technologies (NTHI) - Stock Titan
NeOnc Technologies President Makes Bold Insider Move Signaling Growing Confidence - TipRanks
Neonc president Amir Heshmatpour buys $41,592 of common stock By Investing.com - Investing.com Australia
Neonc president Amir Heshmatpour buys $41,592 of common stock - Investing.com India
Neonc Technologies (NTHI) president adds 10,000 shares in open-market purchase - Stock Titan
NTHI News | NEONC TECHNOLOGIES HOLDINGS (NASDAQ:NTHI) - ChartMill
Neonc Technologies president Amir Heshmatpour buys $45,180 in stock By Investing.com - Investing.com South Africa
Insider Move: NeOnc Technologies President Quietly Boosts His Stake in the Company - TipRanks
NTHI - Finviz
Neonc Technologies (NTHI) insider adds 10,000-share stake - Stock Titan
NTHI SEC FilingsNeOnc Technologies Holdings Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Neonc Technologies president Amir Heshmatpour buys $45,180 in stock - Investing.com
This Walker & Dunlop analyst begins coverage on a bullish note; here are top 5 initiations for Friday - MSN
Neonc Technologies Holdings Inc (NTHI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.98%
0.12%
자본화:
|
볼륨(24시간):